Tempus (TEM) Gets Double-Digit Boost from New Partnerships

Tempus AI Inc. (NASDAQ:TEM) is one of the 9 Stocks Crushing the Market With Surging Returns.

Tempus AI saw its share prices jump by 10 percent on Thursday to finish at $52.56 apiece, as investors cheered its formation of a consortium alongside two health institutions to support the development of an open-source digital pathology platform and viewer.

In an updated report, Tempus AI Inc. (NASDAQ:TEM) said that it joined forces with Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK), under which the listed firm will open-source the existing Paige Image Management System to seed the collaborative, open ecosystem. It will operate independently of its current digital pathology commercial offering.

For illustration purposes only. Photo by Pavel Danilyuk on Pexels

Meanwhile, YNHH and MSK will contribute to defining the vision, governance, and strategic direction of the project.

The parties expect the consortium to add more members over time.

In other news, Tempus AI Inc. (NASDAQ:TEM) also launched on Monday a next-generation sequencing test called xH that uses a whole-genome sequencing approach for the detection of actionable oncologic targets in peripheral blood and bone marrow samples from patients with hematologic malignancies.

Tempus AI Inc. (NASDAQ:TEM) first announced the xH assay for research use only in January 2025. Its performance was established in an analytical validation study using 235 unique specimens, including whole blood, bone marrow, and cell lines.

In addition to high accuracy, the xH assay demonstrated excellent precision, with a positive predictive value of 98.97 percent for single-nucleotide variants and indels, and 100 percent for structural variants. These results indicate a low false-positive rate and support high confidence in the assay’s reported genomic findings.

While we acknowledge the risk and potential of TEM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TEM and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1